This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
Addition/Correction Cite This: Org. Process Res. Dev. XXXX, XXX, XXX−XXX
pubs.acs.org/OPRD
Correction to “Synthetic Strategies toward SGLT2 Inhibitors” Anderson R. Aguillón, Alessandra Mascarello, Natanael D. Segretti, Hatylas F. Z de Azevedo, Cristiano R. W. Guimaraes, Leandro S. M. Miranda, and Rodrigo O. M. A. de Souza* Org. Process Res. Dev. 2018, 22 (4), 467−488. DOI: 10.1021/acs.oprd.8b00017 Errors were found in Schemes 7, 8, 9, 10, 17, and 19. The corrected schemes are given here.
Downloaded via 146.185.203.216 on July 17, 2019 at 16:11:45 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles.
Scheme 7. Synthetic Route to 7 Described by Kobayashi and Co-workers
© XXXX American Chemical Society
A
DOI: 10.1021/acs.oprd.9b00145 Org. Process Res. Dev. XXXX, XXX, XXX−XXX
Organic Process Research & Development
Addition/Correction
Scheme 8. Synthetic Route to 7 Described by Murakata and Co-workers
B
DOI: 10.1021/acs.oprd.9b00145 Org. Process Res. Dev. XXXX, XXX, XXX−XXX
Organic Process Research & Development
Addition/Correction
Scheme 9. Scalable Synthetic Route to 7 Reported by Ohtake and Co-workers
Scheme 10. Scalable Synthetic Route to Tofogliflozin Hydrate Reported by Yang and Co-workers
C
DOI: 10.1021/acs.oprd.9b00145 Org. Process Res. Dev. XXXX, XXX, XXX−XXX
Organic Process Research & Development
Addition/Correction
Scheme 17. Synthesis of Advanced Intermediate 102 Reported by Samas and Co-workers
D
DOI: 10.1021/acs.oprd.9b00145 Org. Process Res. Dev. XXXX, XXX, XXX−XXX
Organic Process Research & Development
Addition/Correction
Scheme 19. Synthetic Route to 123 Developed by Brenek and Co-workers
E
DOI: 10.1021/acs.oprd.9b00145 Org. Process Res. Dev. XXXX, XXX, XXX−XXX